Thomas Luzier, M.D.
Allergy & Immunology Physician in Aberdeen, South Dakota.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,390 in Allergy & Immunology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Thomas Luzier, M.D. reported a CMS MIPS final score of 10.4/100 - below the 83.1 national average - and filed 1,350 Medicare Part D claims in 2023.
- 10.4/100
- MIPS score · -73 vs avg
- 1K
- Part D claims, 2023
- 71%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Thomas Luzier, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
10 2nd percentile higher than 2% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Thomas Luzier, M.D. sits
This provider among allergy & immunology physician peers
Across the 740 allergy & immunology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Thomas Luzier, M.D. writes more Part D claims than 73% of them and scores higher on MIPS quality than 2% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one allergy & immunology physician peer from a representative sample of 60; the gold marker is Thomas Luzier, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Thomas Luzier, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Thomas Luzier, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in South Dakota
How Allergy & Immunology Physician compares to other specialties among South Dakota providers
Allergy & Immunology Physician ranks #177 among South Dakota's specialties (0% of in-state providers)
Each bar is a specialty's share of the South Dakota provider total, by primary NUCC taxonomy. The highlighted bar is Allergy & Immunology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Thomas Luzier, M.D.'s 2023 MIPS final score plotted against the Allergy & Immunology Physician national average
- MIPS Final Score
- 10.4/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Allergy & Immunology Physician) - 10.4/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Allergy & Immunology Physician US NPIs
10.4/100 MIPS final score - 72.7 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Allergy & Immunology Physician. Quality dim: 0. Cost dim: 34.5.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Thomas Luzier, M.D. appears in the CMS NPPES registry as a Allergy & Immunology Physician provider holding M.D. credentials at 201 S LLOYD ST STE W110, Aberdeen, SD, 57401, with a listed phone of (605) 225-0025. NPI 1578595096 was issued on 07/07/2006.
Medicare Part D records for calendar year 2023 show 1,350 prescription claims written by this provider, covering 246 Medicare beneficiaries and totaling roughly $246K in drug spend, split 29% brand-name and 71% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 10.4/100 for the 2023 performance year (Quality 0, Cost 34.5), compared with the national average of 83.1.
Allergy & Immunology Physician is a narrow specialty nationwide, with 3,390 enrolled providers across 52 states and an average of 764 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1578595096 |
|---|---|
| Specialty | Allergy & Immunology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/07/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Thomas Luzier, M.D.'s current license status, disciplinary history, and board certifications with the South Dakota Board of Medical and Osteopathic Examiners in South Dakota before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1578595096 is the unique 10-digit identifier CMS uses to link Luzier across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Thomas Luzier, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$2.1K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
29% brand-name claims vs 71% generic, on 1,350 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,936
- Total Day Supply
- 51,667
- Brand vs Generic
- 29% brand / 71% generic
- Brand Drug Cost
- $225K
- Generic Drug Cost
- $21K
- Antibiotic Claims
- 169
Patient Demographics
- Average Patient Age
- 71.6 years
- Avg HCC Risk Score
- 0.85
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 25, 65-74: 137, 75-84: 64, 85+: 20
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Thomas Luzier, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Montelukast Sodium
Montelukast Sodium
198 claims
- Prednisone
Prednisone
137 claims
- Trelegy Ellipta
Trelegy Ellipta
83 claims
- Doxycycline Hyclate 75
Doxycycline Hyclate
75 claims
- Famotidine 64
Famotidine
64 claims
- Breo Ellipta 63
Breo Ellipta
63 claims
- Omeprazole 40
Omeprazole
40 claims
- Ipratropium Bromide 36
Ipratropium Bromide
36 claims
| Drug | Claims |
|---|---|
| Montelukast Sodium | 198 |
| Prednisone | 137 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 83 |
| Doxycycline Hyclate | 75 |
| Famotidine | 64 |
| Breo Ellipta Fluticasone/Vilanterol | 63 |
| Omeprazole | 40 |
| Ipratropium Bromide | 36 |
| Advair Diskus Fluticasone Propion/Salmeterol | 35 |
| Losartan Potassium | 28 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Allergy & Immunology Physician Overview
How Thomas Luzier, M.D. fits within the Allergy & Immunology Physician landscape nationally.
Thomas Luzier, M.D.'s 1,350 claims are above the specialty average of 764.
Nearby Allergy & Immunology Physician Providers in South Dakota
Other clinicians with the same primary specialty enrolled in South Dakota, drawn from the same CMS NPPES roster as Luzier.
Compare Allergy & Immunology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the South Dakota medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Allergy & Immunology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore South Dakota
Frequently Asked Questions
What is Thomas Luzier, M.D.'s specialty? ▼
How much does Thomas Luzier, M.D. prescribe under Medicare Part D? ▼
What is Thomas Luzier, M.D.'s Medicare quality score? ▼
Where is Thomas Luzier, M.D. located? ▼
What is Thomas Luzier, M.D.'s NPI number? ▼
Does Thomas Luzier, M.D. prescribe more brand-name or generic drugs? ▼
How many Allergy & Immunology Physician providers are there in the US? ▼
What drugs does Thomas Luzier, M.D. prescribe most often? ▼
Does Thomas Luzier, M.D. accept Medicare? ▼
How can I verify Thomas Luzier, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology